Stay informed with the latest updates for the inheritable blood disorders community. Industry Alnylam Announces FDA Lift of Hold on Fitusiran TrialsDec 18, 2017 Industry Shire and Rani Agree to Collaborate on Development of…Dec 14, 2017 Industry Spark Reports Positive Clinical Trial Data on Hemophilia A and…Dec 13, 2017 Industry HEMLIBRA® Shows Prophylactic Efficacy in Hemophilia A Patients…Dec 5, 2017 Industry First Patient Enrolled in ITI Trial Using Eloctate Nov 21, 2017 Industry FDA Grants Orphan Drug Designation for Rofecoxib, Pain…Nov 21, 2017 Industry Alnylam Announces Successful Meeting with FDA on Fitusiran Nov 13, 2017 Industry Study Shows Positive Joint Outcomes in…Nov 6, 2017 Industry FDA Accepts Application for Bayer’s Investigational Hemophilia A TherapyNov 6, 2017 Industry FDA Grants Breakthrough Therapy Designation for…Oct 30, 2017 Industry Shire’s Hemophilia Gene Therapy Granted Orphan Drug Status by FDAOct 27, 2017 Industry UniQure’s Investigational Hemophilia B Gene Therapy to Move Forward in…Oct 20, 2017 Industry Catalyst Reports Positive Results in First…Sep 25, 2017 Industry FDA Accepts License Application and Grants Priority Review for Emicizumab…Sep 8, 2017 Industry Alnylam Reports Patient Death in Fitusiran Clinical StudySep 7, 2017 Pagination First page Previous page … Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Page 15 … Next page Last page
